SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (3083)3/10/2017 4:21:46 PM
From: tuck1 Recommendation

Recommended By
Thehammer

  Read Replies (1) of 3158
 
Well, if GILD must have an IDO inhibitor, NLNK is available for a fraction of the price. Of course, they're a bit behind INCY. Under the radar, that stock has been on a tear since I pointed to it in mom/tif (OK, it sat there for a few months, then went on a tear). And though I came close to buying NLNK a couple of times, I never did. INCY is still a big chunk in my sister's portfolio, so if the deal does go, she'll owe me some bubbly.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News